A Philadelphia jury deliberated more than five hours before ordering Takeda Pharmaceutical Co., was ordered to pay more than $2 million to a woman who claimed the company’s type 2 diabetes drug Actos caused her to develop bladder cancer. The verdict is the latest of thousands involving Actos bladder cancer claims to go to trial. Plaintiff Frances Wisniewski argued that Japan-based Takeda knew of the bladder cancer risks associated with Actos but failed to adequately warn doctors or patients of the risk. Wisniewski is the seventh Actos user to go to trial. A previous case resulted in a $9 billion ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.